Form 483

Primo Medical Group Form 483, 2011-02-18

FDA issued a Form 483 to Primo Medical Group on 2011-02-18 with 1 public-safe observation.

483· Form 483 issued1 observation

Primo Medical Group · Stoughton, United States · Issued February 18, 2011

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Feb 2011
21 CFR 820.75(b)(2)

Documentation of validated process performance

Cited by Maura Rooney

Inspected site

PMPrimo Medical GroupStoughton, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.75(b)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere